Clinical Trials Browser

Phase 2 × Withdrawn × Carcinoma, Merkel Cell × Clear all

Neoplasms, Unknown Primary, Paraganglioma, Pheochromocytoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT04874831 2021-11-18

Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)

Phase 2 Withdrawn

Dermatologic

Carcinoma, Merkel Cell

NCT01913691 2019-12-17

Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma

Phase 2 Withdrawn

Dermatologic

Carcinoma, Merkel Cell

NCT00003514 2013-07-10

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Phase 2 Withdrawn

DermatologicEndocrine

Pituitary Neoplasms, Somatostatinoma, Carcinoma, Merkel Cell, Carcinoma, Islet Cell, Carcinoma, Neuroendocrine, Growth Hormone-Secreting Pituitary Adenoma

Clinical Trials

PUTNET

Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)

Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy